Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Murray

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer Surveys|January 1, 1992
T cell recognition of Epstein-Barr virus associated lymphomasA B Rickinson, R J Murray, J Brooks, et al.
AIDS Research and Human Retroviruses|January 12, 2001
Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapyN M Keane, P Price, S F Stone, et al.
Biotechnology and Bioengineering|August 5, 1995
Continuous monitoring of nitrogenase activity in Azotobacter vinelandii fermentation using off-gas mass spectrometryJ J Prior, P D Christie, R J Murray, et al.
Cardiovascular Drugs and Therapy|February 1, 1991
Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramideT K Knilans, A Varró, P P Nánási, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 15, 2013
Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortalityJ O Robinson, M Phillips, K J Christiansen, et al.
Journal of Virology|October 1, 1988
Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMPR J Murray, D Wang, L S Young, et al.
QJM : Monthly Journal of the Association of Physicians|September 25, 2009
Extensive cutaneous Mycobacterium abscessus infection due to contaminated insulin delivery systemT R Bates, T Keenher, L C O'Reilly, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A)R W Sidwell, J H Huffman, E W Call, et al.
The Journal of Experimental Medicine|July 1, 1992
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignanciesR J Murray, M G Kurilla, J M Brooks, et al.
International Journal of Immunopharmacology|January 1, 1988
The immunological profile of a new immunomodulatory agent, oxamisoleL A Radov, D Kamp, L A Trusso, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer Surveys|January 1, 1992
T cell recognition of Epstein-Barr virus associated lymphomasA B Rickinson, R J Murray, J Brooks, et al.
AIDS Research and Human Retroviruses|January 12, 2001
Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapyN M Keane, P Price, S F Stone, et al.
Biotechnology and Bioengineering|August 5, 1995
Continuous monitoring of nitrogenase activity in Azotobacter vinelandii fermentation using off-gas mass spectrometryJ J Prior, P D Christie, R J Murray, et al.
Cardiovascular Drugs and Therapy|February 1, 1991
Electrophysiologic effects of FPL 13210 on canine Purkinje fiber action potential duration and Vmax comparison to disopyramideT K Knilans, A Varró, P P Nánási, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 15, 2013
Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortalityJ O Robinson, M Phillips, K J Christiansen, et al.
Journal of Virology|October 1, 1988
Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMPR J Murray, D Wang, L S Young, et al.
QJM : Monthly Journal of the Association of Physicians|September 25, 2009
Extensive cutaneous Mycobacterium abscessus infection due to contaminated insulin delivery systemT R Bates, T Keenher, L C O'Reilly, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A)R W Sidwell, J H Huffman, E W Call, et al.
The Journal of Experimental Medicine|July 1, 1992
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignanciesR J Murray, M G Kurilla, J M Brooks, et al.
International Journal of Immunopharmacology|January 1, 1988
The immunological profile of a new immunomodulatory agent, oxamisoleL A Radov, D Kamp, L A Trusso, et al.
Pageof 7